---
figid: PMC4851838__ajcr0006-0577-f1
figlink: /pmc/articles/PMC4851838/figure/fig01/
number: Figure 1
caption: Recurrent genetic alterations and targeted therapies under investigation
  in iCCA. Genetic alterations in tyrosine kinase receptors and downstream RAS/MAPK,
  PI3K/AKT/mTOR effector casades result in aberrant modulation of proliferation, apoptosis
  and cell cycle. Newly identified mutations in MAP3K4 lead to EMT process in iCCA
  through p38/NF-kB signaling pathway. Mutated IDH1/IDH2 result in the accumulation
  of oncogenic metabolite 2HG. Potential targeted therapies against the above alterations
  are currently under clinical trials. Recurrently mutated chromatin remodeling genes
  also present as druggable targets.
pmcid: PMC4851838
papertitle: Genetic profiling of intrahepatic cholangiocarcinoma and its clinical
  implication in targeted therapy.
reftext: Diyang Xie, et al. Am J Cancer Res. 2016;6(3):577-586.
pmc_ranked_result_index: '24873'
pathway_score: 0.9426649
filename: ajcr0006-0577-f1.jpg
figtitle: Recurrent genetic alterations and targeted therapies under investigation
  in iCCA
year: '2016'
organisms: Homo sapiens
ndex: f7730e92-df03-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4851838__ajcr0006-0577-f1.html
  '@type': Dataset
  description: Recurrent genetic alterations and targeted therapies under investigation
    in iCCA. Genetic alterations in tyrosine kinase receptors and downstream RAS/MAPK,
    PI3K/AKT/mTOR effector casades result in aberrant modulation of proliferation,
    apoptosis and cell cycle. Newly identified mutations in MAP3K4 lead to EMT process
    in iCCA through p38/NF-kB signaling pathway. Mutated IDH1/IDH2 result in the accumulation
    of oncogenic metabolite 2HG. Potential targeted therapies against the above alterations
    are currently under clinical trials. Recurrently mutated chromatin remodeling
    genes also present as druggable targets.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK14
  - MAPK13
  - NFKB1
  - PIK3R5
  - PIK3R6
  - AKT3
  - MAPK12
  - MAPK11
  - AKT2
  - MAPK9
  - RAF1
  - MAPK8
  - MAPK3
  - MAPK1
  - AKT1
  - IDH1
  - IDH2
  - MAPK10
  - TP53
  - MAP2K2
  - MAP2K1
  - MET
  - MTOR
  - BAP1
  - PTPN3
  - BRAF
  - PIK3R3
  - PIK3CG
  - PIK3CD
  - PIK3CB
  - PIK3CA
  - PIK3R4
  - ARID1A
  - CCND1
  - EGF
  - EGFR
  - ROS1
  - ARAF
  - KRAS
  - MAP3K4
  - CDK6
  - FGFR2
  - HRAS
  - NRAS
  - Cabozantinib
  - Regorafenib
  - Isocitrate
  - Cancer
  - Cardiomyopathy
  - Cholangiocarcinoma
  - Lung cancer
  - Melanoma
  - Noonan syndrome
genes:
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAP3K4/p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/AKT/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PI3K/AKT/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: RAS/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: RAS/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAS/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: RAS/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAS/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: RAS/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: RAS/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: RAS/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PI3K/AKT/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: IDH1
  symbol: IDH1
  source: hgnc_symbol
  hgnc_symbol: IDH1
  entrez: '3417'
- word: IDH2
  symbol: IDH2
  source: hgnc_symbol
  hgnc_symbol: IDH2
  entrez: '3418'
- word: RAS/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAP3K4/p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAP3K4/p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: TP53,CDK6
  symbol: TP53
  source: hgnc_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: MAP3K4/p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: C-MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: PI3K/AKT/MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PRRM1,BAP1
  symbol: BAP1
  source: hgnc_symbol
  hgnc_symbol: BAP1
  entrez: '8314'
- word: PTPN3
  symbol: PTPN3
  source: hgnc_symbol
  hgnc_symbol: PTPN3
  entrez: '5774'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: ARID1A
  symbol: ARID1A
  source: hgnc_symbol
  hgnc_symbol: ARID1A
  entrez: '8289'
- word: CCND1
  symbol: CCND1
  source: hgnc_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ROS1
  symbol: ROS1
  source: hgnc_symbol
  hgnc_symbol: ROS1
  entrez: '6098'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAS/MAPK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MAP3K4/p38
  symbol: MAP3K4
  source: hgnc_symbol
  hgnc_symbol: MAP3K4
  entrez: '4216'
- word: TP53,CDK6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: FGFR2
  symbol: FGFR2
  source: hgnc_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: RAS/MAPK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS/MAPK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
chemicals:
- word: Cabozantinib
  source: MESH
  identifier: C558660
- word: Regorafenib
  source: MESH
  identifier: C559147
- word: Isocitrate
  source: MESH
  identifier: D007523
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Cholangiocarcinoma
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Melanoma
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
